An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Sales of Lilly's top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of 2024 while its obesity treatment counterpart Zepbound brought in $1.9 ...

Mounjaro and Zepbound are part of a wave of diabetes and obesity medications known as GLP-1 receptor agonists that are soaring in popularity globally due to the amount of weight people lose while ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new ...

Now, an analysis of studies has found that newer medications for type 2 diabetes may help reduce the risk of complications, particularly cardiovascular disease, in some people with type 2 diabetes.

Certain diabetes medications may have additional health benefits for older adults, scientists from the University of Glasgow report. In a recent study assessing the health benefits of diabetes ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

However, typically, type 2 diabetes is treated with medication plus lifestyle modifications. The following article includes several classes of medications that treat type 2 diabetes. Each class works ...